Increase funding for treatment of pulmonary fibrosis & interstitial lung disease Ask the Government to prioritise funding for Pulmonary Fibrosis (PF) and interstitial lung disease services. PF is terminal and kills approximately 8,000 people a year. It has a survival rate worse than many cancers. Increasing funding and creating a care pathway equal to cancer […]
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | |
#BreathingLife #CurePF #PFMonth #pulmonaryfibrosis #UseYourLungs ACEi Action for Pulmonary Fibrosis Angiotensin-converting enzyme inhibitor Angiotensin II receptor blocker Angiotensin modulators Angiotensin peptides Antifibrotic therapies CD1d molecules chronic inflammation Exercise Exercise-based pulmonary rehabilitation fibroblasts fibrosis Forced vital capacity FVC Idiopathic pulmonary fibrosis Interstitial lung disease IPF Macrophages Natural killer T cells NKT Pathogenesis Pleuroparenchymal fibroelastosis Post hoc analysis PPFE Pulmonary Fibrosis Pulmonary Fibrosis Research and Education Hub Pulmonary rehabilitation Slower disease progression tissue fibrosis Upper lobe fibroelastosis